Matikas, A., Tzoras, E., Sarafidis, M., Sifakis, E. G., Bjöhle, J., Barnekow, E., Margolin, S., Isaksson-Friman, E., Kessler, L. E., Zouzos, A., Johansson, H., Hellström, M., Agartz, S., Grybäck, P., Salgkamis, D., Zerdes, I., Wang, K., Hartman, J., Acs, B., Sun, W., Boyaci, C., Villacampa, G., Pascual, T., Gavilá, J., Prat, A., Perou, C., Brandberg, Y., Bergh, J., Hatschek, T., Foukakis, T. (2026). Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial. Nature Communications. https://doi.org/10.1038/s41467-026-71452-6